Physician profile
Ang Li
NPI 1881080703
$35,662.61
in general payments reported to CMS, 2019-2025
15 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $207 · 2021: $312 · 2022: $994 · 2023: $6,895 · 2024: $16K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $8,597 · Honoraria: $8,525 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Travel and Lodging: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,935.34 |
| Food and Beverage | $8,596.54 |
| Honoraria | $8,525.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Travel and Lodging | $1,249.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $11,130.77 | 2022-2025 | Streamline, Clearpath, Ahmed Glaucoma Valve |
| Nova Eye, INC. | $10,990.32 | 2023-2025 | |
| Abbvie INC. | $5,904.59 | 2022-2025 | |
| Alcon Vision LLC | $4,257.55 | 2019-2025 | Hydrus Microstent, Argos, Clareon |
| Sight Sciences, INC. | $758.80 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Microsurgical Technology, INC. | $719.74 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $419.46 | 2019-2021 | |
| Glaukos Corporation | $387.58 | 2024-2025 | Idose, Idosetr |
| Tarsus Pharmaceuticals, INC. | $355.86 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $222.61 | 2022 | |
| Allergan, INC. | $174.16 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $119.70 | 2019 | |
| Ocular Therapeutix, INC. | $89.42 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $68.53 | 2024 | Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $63.52 | 2022-2023 | Vyzulta, Lotemax Sm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ang Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.